Richmond, United States
BRAINBox Solutions, Inc., founded in 2018 and headquartered in the United States, is at the forefront of the biotechnology, health care, and health and wellness sectors. The company is dedicated to revolutionizing the management of Traumatic Brain Injury (TBI) with its slogan, "Providing the Comprehensive TBI Solution."
Their innovative multi-modality approach integrates blood biomarker panels, applicable at point-of-care and standard laboratory systems, along with neurocognitive testing. This suite of tools offers objective evidence of injury and enhances the prediction of patient recovery, positioning the company as a leader in TBI solutions.
Recently, BRAINBox Solutions secured a Series B investment as of 01 October 2023. The round was led by Genoa Ventures, underscoring strong investor confidence in the company's potential to make significant impacts in the healthcare landscape.
